Anti-beta Amyloid 37-42 antibody - BSA and Azide free
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Polyclonal Amyloid-beta precursor protein antibody. Carrier free. Suitable for ELISA and reacts with Synthetic peptide - Human samples. Cited in 14 publications.
View Alternative Names
A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II
- ELISA
Supplier Data
ELISA - Anti-beta Amyloid 37-42 antibody - BSA and Azide free (AB34376)
ELISA using ab34376 at varying antibody concentrations and antigen concentration at 1000 ng/mL.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Beta Amyloid 37-42 fragment contributes to plaque formation found in the brains of affected individuals. This peptide can become part of a complex aggregating into oligomers and fibrils. These structures are important due to their impact on neural tissue and are studied extensively for their neurotoxic potential and involvement in synaptic dysfunction.
Pathways
Scientists have linked Beta Amyloid 37-42 activity to pathways involving proteolysis and amyloidogenic processing. It is heavily involved in the amyloid cascade pathway a series of events leading to peptide aggregation. Its interactions with other proteins such as presenilins in the γ-secretase complex are critical. These related proteins modulate β-secretase activity consequently influencing peptide production and accumulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
International journal of medical sciences 22:1736-1749 PubMed40225859
2025
Applications
Unspecified application
Species
Unspecified reactive species
ACS omega 10:7256-7263 PubMed40028141
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical kidney journal 18:sfae283 PubMed39781476
2025
Applications
Unspecified application
Species
Unspecified reactive species
Alzheimer's & dementia (Amsterdam, Netherlands) 13:e12242 PubMed34692980
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neurology 12:619388 PubMed34671305
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 13:657794 PubMed34122041
2021
Applications
Unspecified application
Species
Unspecified reactive species
ACS chemical neuroscience 12:1376-1383 PubMed33825443
2021
Applications
Unspecified application
Species
Unspecified reactive species
European journal of neurology 28:1479-1489 PubMed33370497
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed33383667
2020
Applications
Unspecified application
Species
Unspecified reactive species
Alzheimer's research & therapy 11:111 PubMed31881963
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com